These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32083944)

  • 1. Evaluation of QuantiFERON-TB Gold Plus for Predicting Incident Tuberculosis among Recent Contacts: A Prospective Cohort Study.
    Gupta RK; Kunst H; Lipman M; Noursadeghi M; Jackson C; Southern J; Imran A; Lozewicz S; Abubakar I
    Ann Am Thorac Soc; 2020 May; 17(5):646-650. PubMed ID: 32083944
    [No Abstract]   [Full Text] [Related]  

  • 2. Implementing contact tracing for tuberculosis in Kyrgyz Republic and risk factors for positivity using QuantiFERON-TB Gold plus.
    Corbett C; Kulzhabaeva A; Toichkina T; Kalmambetova G; Ahmedov S; Antonenka U; Iskakova A; Kosimova D; Migunov D; Myrzaliev B; Sahalchyk E; Umetalieva N; Vogel M; Kadyrov A; Hoffmann H
    BMC Infect Dis; 2020 Oct; 20(1):746. PubMed ID: 33046016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First evaluation of QuantiFERON-TB Gold Plus performance in contact screening.
    Barcellini L; Borroni E; Brown J; Brunetti E; Campisi D; Castellotti PF; Codecasa LR; Cugnata F; Di Serio C; Ferrarese M; Goletti D; Lipman M; Rancoita PM; Russo G; Tadolini M; Vanino E; Cirillo DM
    Eur Respir J; 2016 Nov; 48(5):1411-1419. PubMed ID: 27390280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter Study.
    Pérez-Recio S; Pallarès N; Grijota-Camino MD; Sánchez-Montalvá A; Barcia L; Campos-Gutiérrez S; Pomar V; Rabuñal-Rey R; Balcells ME; Gazel D; Montiel N; Vicente D; Goić-Barišić I; Schön T; Paues J; Mareković I; Cacho-Calvo J; Barac A; Goletti D; García-Gasalla M; Barcala JM; Tórtola MT; Anibarro L; Suárez-Toste I; Moga E; Gude-Gonzalez MJ; Naves R; Karslıgil T; Martin-Peñaranda T; Stevanovic G; Trigo M; Rubio V; Karaoğlan İ; Bayram N; Alcaide F; Tebé C; Santin M;
    Microbiol Spectr; 2021 Dec; 9(3):e0097221. PubMed ID: 34756079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-step QuantiFERON screening of adult contacts: a prospective cohort study of tuberculosis risk.
    Haldar P; Thuraisingam H; Patel H; Pereira N; Free RC; Entwisle J; Wiselka M; Hoskyns EW; Monk P; Barer MR; Woltmann G
    Thorax; 2013 Mar; 68(3):240-6. PubMed ID: 22956558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the Development of Tuberculosis with the Tuberculin Skin Test and QuantiFERON Testing.
    Altet N; Dominguez J; Souza-Galvão ML; Jiménez-Fuentes MÁ; Milà C; Solsona J; Soriano-Arandés A; Latorre I; Lara E; Cantos A; Ferrer MD; Orcau À; Ruiz-Manzano J; Caylà J
    Ann Am Thorac Soc; 2015 May; 12(5):680-8. PubMed ID: 25699406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
    Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
    BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective cohort study of latent tuberculosis in adult close contacts of active pulmonary tuberculosis patients in Korea.
    Park SH; Lee SJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Kim HJ; Menzies D
    Korean J Intern Med; 2016 May; 31(3):517-24. PubMed ID: 27052266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of QuantiFERON tuberculosis gold-in-tube test for detecting latent tuberculosis infection among close household contacts of confirmed tuberculosis patients in Accra, Ghana.
    Mensah GI; Sowah SA; Yeboah NY; Addo KK; Jackson-Sillah D
    Int J Mycobacteriol; 2017; 6(1):27-33. PubMed ID: 28317801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection.
    Gupta D; Kumar S; Aggarwal AN; Verma I; Agarwal R
    Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):95-101. PubMed ID: 22117500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of confirmatory interferon-gamma release assays in school outbreaks of tuberculosis in South Korea.
    Kim HJ; Lee GH; Ryoo S; Oh SY; Lee JB; Kim JH; Shin C; Lee SH
    Int J Tuberc Lung Dis; 2015 May; 19(5):576-81. PubMed ID: 25868027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative IFN-γ Release Assay and Tuberculin Skin Test Results to Predict Incident Tuberculosis. A Prospective Cohort Study.
    Gupta RK; Lipman M; Jackson C; Sitch AJ; Southern J; Drobniewski F; Deeks JJ; Tsou CY; Griffiths C; Davidson J; Campbell C; Stirrup O; Noursadeghi M; Kunst H; Haldar P; Lalvani A; Abubakar I
    Am J Respir Crit Care Med; 2020 Apr; 201(8):984-991. PubMed ID: 31825645
    [No Abstract]   [Full Text] [Related]  

  • 13. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
    Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y
    Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agreement between QuantiFERON®-TB Gold In-Tube and the tuberculin skin test and predictors of positive test results in Warao Amerindian pediatric tuberculosis contacts.
    Verhagen LM; Maes M; Villalba JA; d'Alessandro A; Rodriguez LP; España MF; Hermans PW; de Waard JH
    BMC Infect Dis; 2014 Jul; 14():383. PubMed ID: 25012075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of QuantiFERON(®)-TB Gold In-Tube in tuberculosis contact investigation: experience in a tuberculosis unit.
    Gonzślez-Moreno J; García-Gasalla M; Gállego-Lezaun C; Fernández-Baca V; Mir Viladrich I; Cifuentes-Luna C; Serrano Bujalance A; Salom Vallespir A; Payeras Cifre A
    Infect Dis (Lond); 2015 Apr; 47(4):244-51. PubMed ID: 25692351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programmatic impact of using QuantiFERON®-TB Gold in routine contact investigation activities.
    Grinsdale JA; Ho CS; Banouvong H; Kawamura LM
    Int J Tuberc Lung Dis; 2011 Dec; 15(12):1614-20. PubMed ID: 22118167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculin skin test and/or interferon gamma release assay: is it still time to debate?
    Sanduzzi A; Marchetiello I; Bocchino M; Boccia G; De Caro F
    Infez Med; 2017 Mar; 25(1):80-81. PubMed ID: 28353462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Feasibility Study for Diagnosis of Latent Tuberculosis Infection Using an IGRA Point-of-Care Platform in South Korea.
    Hur YG; Hong JY; Choi DH; Kim A; Park SY; Kwon M; Kang K; Lee JM; Dockrell HM; Lee Y; Joo H; Cho SN
    Yonsei Med J; 2019 Apr; 60(4):375-380. PubMed ID: 30900424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contact tracing in low-incidence tuberculosis settings.
    van Leth F; Borgdorff M
    Int J Tuberc Lung Dis; 2011 Dec; 15(12):1566. PubMed ID: 22118163
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of the QuantiFERON-TB Gold interferon-gamma release assay for screening transplant candidates: a single-center retrospective study.
    Theodoropoulos N; Lanternier F; Rassiwala J; McNatt G; Preczewski L; DeMayo E; Stosor V; Ison MG
    Transpl Infect Dis; 2012 Feb; 14(1):1-8. PubMed ID: 21883759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.